Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. XRN
XRN logo

XRN Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Chiron Real Estate Inc (XRN) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
37.560
1 Day change
0.62%
52 Week Range
38.650
Analysis Updated At
2026/06/19
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Chiron Real Estate Inc (XRN) is not a strong buy for a beginner investor with a long-term horizon at this time. The company's ongoing transition to senior housing operating properties is dilutive in the near term, and technical indicators do not suggest a strong entry point. Analysts are mixed, with no clear bullish sentiment, and there are no significant positive catalysts or recent news to drive immediate upside.

Technical Analysis

The MACD is negative and expanding (-0.168), indicating bearish momentum. The RSI is neutral at 31.745, and moving averages are converging, suggesting indecision. Key support is at 35.086, with resistance at 36.285. The stock is trading near support, but no strong bullish signals are present.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
1
Buy
8

Positive Catalysts

  • The company is pivoting towards higher-growth senior housing operating properties, which could unlock value in the long term. Analysts see potential upside in the legacy portfolio's discounted valuation.

Neutral/Negative Catalysts

  • The transition is dilutive to earnings in the near term, and the company has recently cut dividends and withdrawn guidance. Analysts have downgraded the stock, and there is no significant insider or hedge fund activity. Technical indicators show no clear bullish momentum.

Financial Performance

No financial data available for analysis.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts are mixed, with ratings ranging from Neutral to Buy. Recent price target changes include a downgrade from $50 to $38 and an increase from $33 to $39, reflecting uncertainty around the company's transition and near-term performance.

Wall Street analysts forecast XRN stock price to rise
0 Analyst Rating
0
Wall Street analysts forecast XRN stock price to rise
0 Buy
0 Hold
0 Sell
0
Current: 37.330
sliders
Low
0
Averages
0
High
0
0
Current: 37.330
sliders
Low
0
Averages
0
High
0
Alliance Global
Buy
maintain
$40 -> $43
AI Analysis
2026-07-01
Reason
Alliance Global
Price Target
$40 -> $43
AI Analysis
2026-07-01
maintain
Buy
Reason
Alliance Global raised the firm's price target on Chiron Real Estate to $43 from $40 and keeps a Buy rating on the shares after the company announced disposition of seven inpatient rehab facilities, in-line with the company's portfolio transformation strategy.
Raymond James
Market Perform
initiated
$NULL
2026-06-16
Reason
Raymond James
Price Target
$NULL
2026-06-16
initiated
Market Perform
Reason
Raymond James initiated coverage of Chiron Real Estate with a Market Perform rating and no price target. The firm says the company's transition from secondary market outpatient medical to U.S. senior housing operating portfolio will prove dilutive to earnings and near-term value. Chiron's organic upside from its investments will take time and "provide little near-term measuring sticks for performance," the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for XRN
Unlock Now

People Also Watch